GlassScriptPhysician profile
Kyle R Yorgason
NPI 1629223110
$2,549.00
in general payments reported to CMS, 2019-2025
18 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $331 · 2021: $1,450 · 2022: $15.56 · 2023: $20.97 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $1,251.15 | 2020-2023 | |
| Stryker Corporation | $227.11 | 2019-2021 | |
| Organogenesis INC. | $179.82 | 2019-2020 | |
| Treace Medical Concepts, INC. | $155.00 | 2020 | |
| Medline Industries LP | $139.73 | 2025 | |
| Sawtooth Surgical Solutions INC | $109.68 | 2025 | |
| Smith+Nephew, INC. | $80.83 | 2019-2020 | |
| Zyla Life Sciences, INC. | $79.90 | 2019 | |
| Zimmer Biomet Holdings, INC. | $71.38 | 2020 | |
| Sandoz INC. | $70.23 | 2019 | |
| Depuy Synthes Sales INC. | $61.78 | 2021 | |
| Paragon 28, INC. | $22.43 | 2019 | |
| Misonix INC | $21.34 | 2019 | |
| Osiris Therapeutics INC. | $19.98 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.27 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $15.56 | 2022 | |
| Pfizer INC. | $13.32 | 2019 | |
| Integra Lifesciences Corporation | $12.49 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Yorgason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.